The Action Collaborative on Clinician Well-Being & Resilience is a network of more than 60 organizations committed to reversing trends in clinician burnout. The Collaborative has three goals: 1) Improve baseline understanding of challenges to clinician well-being; 2) Raise the visibility of clinician stress and burnout; and 3) Elevate evidence-based, multidisciplinary solutions that will improve patient care by caring for the caregiver.
The Action Collaborative on Countering the U.S. Opioid Epidemic is a public-private partnership comprised of government, communities, health systems, provider groups, payers, industry, nonprofits, academia, and more. The Collaborative is committed to sharing knowledge, aligning ongoing initiatives, and advancing collective, multisector solutions to improve outcomes for individuals, families, and communities affected by the opioid crisis.
The Culture of Health Program is a multiyear collaborative effort to identify strategies to create and sustain conditions that support equitable good health for all Americans. The program includes a series of consensus studies from the National Academies of Sciences, Engineering, and Medicine, as well as public workshops, community events, and tools for stakeholders.
The NAM administers four national health policy fellowship and scholarship programs: the FDA Tobacco Regulatory Science Fellowship; the Distinguished Nurse Scholar-in-Residence; the NAM Fellowship; and the Robert Wood Johnson Foundation Health Policy Fellows. The NAM has also begun the International Health Policy Fellowship program. The NAM also hosts the Emerging Leaders in Health and Medicine Program, increases the Academy’s engagement with exceptional early- and mid-career professionals working in biomedical science, health care delivery, health policy, and related fields
The Healthy Longevity Global Grand Challenge aims to build a worldwide movement to increase physical, mental, and social well-being for people as they age. The initiative will have two components: a prize competition to catalyze breakthrough innovations from any field, and an evidence-based report authored by an international commission.
This joint NAS-NAM initiative launched in 2015 to inform decision-making related to recent advances in human genome-editing research. The initiative includes two international summits as well as a consensus study on the scientific underpinnings of human genome-editing technologies, their potential use in biomedical research and medicine, and the clinical, ethical, legal, and social implications of their use.
The Leadership Consortium for a Value & Science-Driven Health System is a trusted venue for national leaders in health and health care to work toward a common commitment to effective, innovative care that consistently adds value to patients and society. Members are leaders from core stakeholder communities committed to stewarding advances in science, value and culture necessary for a health system that continuously learns and improves in fostering healthier people.
The NAM called on more than 150 leading researchers, scientists, and policy makers from across the United States to provide expert guidance on 19 priority issues for U.S. health policy. The resulting collection of expert papers is organized around three overarching goals for the United States: better health and well-being; high-value health care; and strong science and technology.